samedan logo
 
 
 
spacer
home > pmps > winter 2003 > success factors for the cargo transportation of pharmaceuticals
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Success Factors for the Cargo Transportation of Pharmaceuticals

For pharmaceutical manufacturers, transportation is considered the weakest link in the supply chain. The high value of pharmaceutical products, above all considering the importance of effecting the health of people, leads the producers to choose a trustworthy transportation company. In fact, when it comes to pharmaceutical products, it's not just the speed of the transportation that is essential; the goods need to be expertly handled and kept at their ideal temperature throughout their journey. Additionally, given that most of these products are theft-sensitive, the employment of seamless security measures is essential. Moreover, when it comes to air cargo transportation, IATA regulations must also be taken into account.

What are the success factors for air cargo companies in providing satisfactory transport solutions for the pharmaceutical industry?

Technology definitely plays an important role in the transportation of pharmaceuticals. Nowadays, the market offers a wide choice of sophisticated containers, enabling the maintenance of temperatures between -20 and +200C. Cutting-edge tracking systems as well as state-of-the art alarm devices are also available, allowing companies to seamlessly pinpoint the status of shipments in real-time and enabling proactive action in case of emergency. Nevertheless, there is still a lot to do to ensure the cool-chain demanded by pharmaceutical manufacturers when transportation is involved and, so far, the real added value has proved to be the 'human factor'. Only with a dedicated, well- trained personnel can, air cargo companies assure that the shipment is under control from acceptance to delivery.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
PMPS talks to Francis Ramuz, Cool Products Specialist at Swiss WorldCargo

Francis Ramuz is a seasoned professional with over 30 years' experience in the airline industry. After starting his personal career at Swissair, he has worked in different business units at Sabena. He joined Swissair again six years ago and continued working in the same position at Swiss WorldCargo, once Swiss International Air Lines was founded in 2002. He is currently Head of Import Management and Cool Products - Europe, based at Zurich Airport.

spacer
Francis Ramuz
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

IONTAS announces a new collaboration to identify novel immunotherapy targets

Cambridge, UK, 07 May 2020: IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, today announced it has entered into a collaboration agreement with Inotrem, a specialist in immunotherapy for acute and chronic inflammatory syndromes. As part of the agreement, IONTAS will apply its Mammalian Display technology to identify antibodies involved in the TREM-1 pathway.
More info >>

White Papers

Points to Consider When Developing a TMF (Trial Master File) Strategy

Phlexglobal Ltd

Many organizations are currently outsourcing clinical trial activities to one or more contract research organizations (CROs). This strategy enables companies to leverage specialized expertise and take advantage of flexible resourcing throughout the conduct of a clinical trial. Outsourcing minimizes the costs of recruiting experts, building a team and maintaining an infrastructure. However, it can also add complexity as the organization looks to meets its compliance obligations regarding clinical trial documentation. The documentation referred to in Article 15(5) of Directive 2001/20/EC as the trial master file shall consist of essential documents, which enable both the conduct of a clinical trial and the quality of the data produced to be evaluated.1 This essential study specific documentation is also known as the TMF. As organizations try to minimize their reliance on paper files, the electronic TMF (eTMF) has emerged. A current industry initiative to standardize the organization of this content is known as the TMF Reference Model. This model is helping standardization efforts across paper and electronic systems. As companies implement outsourcing strategies, CROs and sponsor organizations look for a common foundation on which to build their TMF capabilities. The following paper outlines some of the challenges organizations face when outsourcing clinical trial activities to multiple contract research organizations and a strategy to facilitate partnering and management of trial information between sponsors and CROs.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement